New targeted drug shows promise for Hard-to-Treat cancers
NCT ID NCT06130553
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 27 times
Summary
This early-phase study tests a new drug called AZD3470 in people with advanced solid tumors that lack a gene called MTAP. The drug is designed to block a protein these cancer cells need to grow. The study will check safety, find the best dose, and see if the drug shrinks tumors when used alone or with other cancer treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS THAT ARE MTAP DEFICIENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGSan Francisco, California, 94143, United States
-
Research Site
WITHDRAWNWest Hollywood, California, 90048, United States
-
Research Site
RECRUITINGNew Haven, Connecticut, 06510, United States
-
Research Site
RECRUITINGBaltimore, Maryland, 21231, United States
-
Research Site
RECRUITINGPortland, Oregon, 97239, United States
-
Research Site
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
-
Research Site
RECRUITINGProvidence, Rhode Island, 02903, United States
-
Research Site
RECRUITINGFairfax, Virginia, 22031, United States
-
Research Site
RECRUITINGMelbourne, 3000, Australia
-
Research Site
RECRUITINGBeijing, 100142, China
-
Research Site
RECRUITINGChengdu, 610041, China
-
Research Site
RECRUITINGShanghai, 200433, China
-
Research Site
NOT_YET_RECRUITINGVillejuif, 94805, France
-
Research Site
RECRUITINGChūōku, 104-0045, Japan
-
Research Site
RECRUITINGKashiwa, 227-8577, Japan
-
Research Site
RECRUITINGAmsterdam, 1066CX, Netherlands
-
Research Site
RECRUITINGSeoul, 03080, South Korea
-
Research Site
RECRUITINGSeoul, 06351, South Korea
-
Research Site
RECRUITINGBarcelona, 8035, Spain
-
Research Site
RECRUITINGMadrid, 28027, Spain
Conditions
Explore the condition pages connected to this study.